Report Details

Biobanks - how to find business trends, R&D, and revenue forecasts

What does the future hold for medical biobanks? Now you get technological and commercial predictions from 2014. Stay ahead, then, for data, helping your authority. There you explore developmental trends, sales results, opportunities, and revenue forecasts.

That new report by visiongain shows you what's possible for biobanking and associated technology to improve healthcare. Avoid missing out. Instead find prospects for that biomedical industry and market, discovering expected trends, progress and gains.

Read on to explore those technologies and services for human medicine, seeing how high revenues can go.

Forecasts and other information showing lucrative possibilities for biorepositories

That study gives you sales predictions to 2024 at overall world, submarket and national level. You also get unit sales predictions. There, for biosample and biospecimen applications, you investigate where demand and money lie.

That way you can avoid struggles to find information. Besides revenue forecasting, our new work shows results, growth rates, and market shares. There you explore those technologies for medical R&D - applications in drug development.

You discover 72 tables, 73 charts, and five interviews with authorities in that industry.

So help your research, analyses, and decisions on storage of human biological samples (HBS). Also benefit your influence.

And the following sections explain what our new investigation gives you.

Forecasting of that world market and its segments - what's likely to happen?

What're the secrets of that industry's progress? Discover in our report overall world revenue to 2024 for storing human cell, tissue and fluid samples, with discussions.

Also find individual revenue predictions to 2024 for nine submarkets at world level:
• Biobanking for research
• Biobanking for therapeutic uses.

That study also forecasts the number of samples stored in those two fields. And it gives biobanking revenue forecasting to 2024 by research application:
• Human tissues (also with sub-forecasts for public sector and commercial uses)
• Stem cells
• Other biological sample banking applications (inc. DNA and body fluids).

And it predicts stem cell banking revenues to 2024 for therapeutic uses:
• Umbilical cord stem cell banking
• Adult stem cell banking.

That study also forecasts the number of stem cell samples banked.

There you assess outlooks for sales expansion, hearing where you could gain. That work investigates competition and demand, showing technological and commercial possibilities.

So discover what's happening. You also assess geographical revenue potentials.

Healthcare in regional markets - what outlooks for biorepository demand and provision?

In developed and developing countries, opportunities for companies providing biobanking facilities, products, services, consumables, and technology will occur from 2014. See where and how.

So our analyses show you individual revenue forecasts to 2024 for 12 national markets:
• United States (US)
• Japan
• Germany, France, UK, Italy, Spain (EU5), and Netherlands
• Brazil, Russia, India, and China (BRIC nations).

There you find countries with highest revenues, demands, and potential growth in usage and sales. Explore progress, needs, opportunities and competitors. And see the gains possible.

Also what events, challenges and advances in technology affect that industry and market? Our work shows you, discussing progress, policies, and trends influencing biorepositories.

Forces affecting developers, producers, and sellers of those medical resources and libraries

The report explains issues, events, and contributions affecting that indu

Table Of Contents

1. Executive Summary

1.1 What Does This Report Cover?
1.1.1 The Human Tissue Banking Market - Our Definition
1.1.2 The Stem Cell Banking Market - Our Breakdown
1.2 Biobanking for Medicine: Technology, Industry and Market 2014-2024 Overview
1.3 Chapter Outlines
1.4 Speculative Aspects of Assessing the Biobanking Market
1.5 Research and Analysis Methods
1.6 Glossary of Terms in this Report

2. Introduction to Biobanking and its Applications

2.1 What is Biobanking?
2.2 Main Features of Biobanks
2.3 What Processes are Involved in Biobanking?
2.4 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.4.1 Volunteer Group: Population- vs. Disease-Based
2.4.2 Ownership Structure: Public vs. Private
2.5 The Guidelines and Standards for Biobanking
2.6 Laws and Regulations for Biobank-Based Research
2.6.1 HIPAA Amendments
2.7 Biobanking and the Pharmaceutical Industry
2.7.1 Biobanking in Research, Drug Discovery and Development Understanding Disease Pathways Drug Discovery Biomarker Discovery in Drug Development
2.7.2 Biobanking for Therapeutics
2.7.3 Biobanking in Clinical Trials

3. Biobanking for Medicine: World Market 2014-2024

3.1 The World Biobanking for Medicine Market in 2013
3.2 Biobanking for Medicine: Research vs. Therapeutics in 2018 and 2024
3.3 World Biobanking for Medicine Market: Overarching Revenue Forecast 2014-2024
3.4 Biobanks Stored Almost 1.3 Billion Specimens in 2013, and That Figure Increases
3.5 The Biobanking for Medicine Market by Sector: Grouped Revenue Forecasts 2014-2024
3.6 Biobanking for Research: A $10bn Industry
3.6.1 Biobanking for Research: Revenue Forecast 2014-2024
3.6.2 Driving Forces Outweigh Restraints on the Biobanking Industry for Research
3.7 Biobanking for Future Therapeutic Use: A Worthwhile Endeavour or a Waste of Money?
3.7.1 Arguments Against Commercial Stem Cell Banking for Therapeutic Purposes
3.7.2 Biobanking for Future Therapeutic Use: Revenue Forecast 2014-2024
3.7.3 Driving and Restraining Forces Influencing the Biobanking Market for Therapeutic Use, 2014-2024

4. Biobanking for Research Purposes

4.1 Breakdown of the Biobanking for Research Market by Tissue Type, 2013
4.2 Biobanking for Research in 2018 and 2024: Comparison by Tissue Type
4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts 2014-2024
4.4 How Many Specimens are Biobanked for Research?
4.5 The Human Tissue Banking Market for Research in 2013
4.6 The Human Tissue Banking Market for Research: Revenue Forecast 2014-2024
4.7 The Human Tissue Banking Market: Commercial vs. Public Sector
4.7.1 Commercial Human Tissue Banks: Revenue Forecast 2014-2024
4.7.2 Public Sector Human Tissue Banks: Revenue Forecast 2014-2024
4.8 The Stem Cell Banking Market for Research in 2013
4.9 The Stem Cell Banking Market for Research: Revenue Forecast 2014-2024
4.9.1 A Shift in RandD Towards Stem Cells
4.10 Banking of Other Biologic Specimens for Research in 2013
4.11 Banking of Other Biologic Specimens for Research: Revenue Forecast 2014-2024

5. Stem Cell Banking for Future Therapeutic Use

5.1 Stem Cell Banking for Therapeutic Use in 2013: A Breakdown by Stem Cell Type
5.2 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenue and Market Share, 2018 and 2024
5.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: A Grouped Revenue Forecast
5.4 How Many Stem Cell Samples Are Biobanked Each Year?
5.5 The Umbilical Cord Blood Banking Market in 2013
5.5.1 Private vs. Public Cord Blood Banking
5.5.2 Umbilical Cord Blood Banking: The Controversies
5.6 The Umbilical Cord Blood Banking Market: Revenue Forecast 2014-2024
5.7 The Adult Stem Cell Banking Market in 2013
5.8 The Adult Stem Cell

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Global Markets for Drug-Device Combinations

Global Markets for Drug-Device Combinations

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The sales of drug-device combination products reached $21.4 billion in 2013 and $22 billion in 2014. This market is expected to grow to $31 billion in 2019, with a compound annual growth ...

World Intravenous Immunoglobulin (IVIg) Industry

World Intravenous Immunoglobulin (IVIg) Industry

  • $ 4 950
  • Industry report
  • January 2015
  • by Global Industry Analysts

This report analyzes the worldwide markets for Intravenous Immunoglobulin (IVIg) in US$ Million and in Kilograms. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, ...

Blood & Organ Bank Lines World Report

Blood & Organ Bank Lines World Report

  • $ 4 609
  • Industry report
  • February 2015
  • by PureData

BLOOD & ORGAN BANK LINES WORLD REPORT The Blood & Organ Bank Lines World Report gives Market Consumption / Products / Services for over 200 countries by 6 to 10-Digit NAICS Product Codes by 3 Time series: ...

Blood & Organ Bank Lines Asia Report

February 2015 $ 2 969

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.